ARCHIVES

FDA’s Commitment To Cancer No Different Than Other Diseases, Kessler Tells Advocate

This article is from The Cancer Letter archive.

Vol. 18 No. 33 | August 14, 1992

Download PDF Visit The Full Archive

Related Articles

Letter: ORI And Plotkin Should Release Report

June 23, 1995

Institutinal Training Awards Hardest Hit As New Budget Cuts Will Slash Into Noncompeting Grants

March 13, 1981

June Panel Meeting Dropped

June 3, 1977

In Brief: Kennedy’s Oversight Hearings Will Include Cancer Program, Important To Act Renewal

January 26, 1979

Trial Begins To Test Method To Test For Colorectal Cancer

May 28, 2004

FDA Should Delay Provenge Decision Pending Definitive Trial Results, ODAC Chairman Writes.

April 27, 2007